tetanus and diphtheria toxoids
Commercial- Indications
- Tetanus, Diphtheria
Company intelligence / Profile preview
MassBiologics is the only nonprofit FDA-approved manufacturer of vaccines in the US. It has a long history of developing and manufacturing biologic products for public health needs. In recent years it has advanced four treatments into clinical trials—including a promising monoclonal antibody prophylaxis against Lyme disease now in phase 1 trials—and provides cGMP manufacturing services for gene therapies that have reached regulatory approval in Europe
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MassBiologics.